Table of Contents
TABLE OF CONTENTS
LIST OF EXHIBITS
EXECUTIVE SUMMARY
METHODOLOGY
1.0 CORONARY ARTERY DISEASE
- 1.1 Introduction
- 1.2 An Overview of Coronary Artery Disease
- 1.3 Epidemiology
- 1.4 Existing Diagnosis and Treatment Options for Coronary Artery Disease
- 1.4.1 Diagnosis
- 1.4.2 Treatment
- 1.5 Future Outlook
2.0 DIAGNOSTIC IMAGING DEVICES
- 2.1 Overview
- 2.2 Intravascular Ultrasound
- 2.2.1 Technology Overview
- 2.2.2 Market Potential
- 2.2.3 Competitor Insights
- 2.3 Vulnerable Plaque Diagnosis
- 2.3.1 Technology Overview
- 2.3.1.1 Computed Tomography
- 2.3.1.2 Magnetic Resonance Imaging
- 2.3.1.3 Near-Infrared Spectroscopy
- 2.3.1.4 Optical Coherence Tomography
- 2.3.1.5 Thermography
- 2.3.2 Market Potential
- 2.3.3 Competitor Insights
- 2.3.3.1 Computed Tomography
- 2.3.3.2 Magnetic Resonance Imaging
- 2.3.3.3 Near-Infrared Spectroscopy
- 2.3.3.4 Optical Coherence Tomography
- 2.3.3.5 Thermography
3.0 REVASCULARIZATION DEVICES
- 3.1 Overview
- 3.2 Novel Stent Technologies
- 3.2.1 Technology Overview
- 3.2.1.1 Bioabsorbable Stents
- 3.2.1.2 Specially Coated Drug-Eluting Stents
- 3.2.2 Market Potential
- 3.2.2.1 Bioabsorbable Stents
- 3.2.2.2 Specially Coated Drug-Eluting Stents
- 3.2.2.3 Overall Coronary Stent Market
- 3.2.3 Competitor Insights
- 3.2.3.1 Bioabsorbable Stents
- 3.2.3.2 Specially Coated Drug-Eluting Stents
- 3.3 Synthetic Grafts
- 3.3.1 Technology Overview
- 3.3.2 Market Potential
- 3.3.3 Competitor Insights
- 3.4 Remote Navigation Technologies
- 3.4.1 Technology Overview
- 3.4.2 Market Potential
- 3.4.3 Competitor Insights
4.0 NEOVASCULARIZATION THERAPIES
- 4.1 Overview
- 4.2 Therapeutic Angiogenesis
- 4.2.1 Technology Overview
- 4.2.1.1 Gene Therapy
- 4.2.1.2 Stem Cell Therapy
- 4.2.2 Market Potential
- 4.2.3 Competitor Insights
- 4.2.3.1 Gene Therapy
- 4.2.3.2 Stem Cell Therapy
APPENDIX A: MRG ACRONYMS AND INITIALISMS
APPENDIX B: ADDITIONAL COMPETITOR INFORMATION
List of Exhibits
EXECUTIVE SUMMARY
- Exhibit 1: New Imaging Technology Procedures, US, 2009-2018
- Exhibit 2: PCIs, by Type, US, 2018
- Exhibit 3: Therapeutic Angiogenesis Procedures, US, 2013-2018
CHAPTER 1: CORONARY ARTERY DISEASE
- Exhibit 4: Frequently Used CAD Terminology
- Exhibit 5: Stages of Lesion Development
- Exhibit 6: Common CAD Risk Factors
- Exhibit 7: Global Life Expectancy, 2006
- Exhibit 8: CAD Incidence, by Region, 2007-2013 (Tabular Format)
- Exhibit 9: Symptoms of CAD
- Exhibit 10: CAD Treatment Options
CHAPTER 2: DIAGNOSTIC IMAGING DEVICES
- Exhibit 11: IVUS Procedures, by Region, 2006-2011
- Exhibit 12: New Imaging Technology Penetration, as a % of Total, US,
2009-2018
- Exhibit 13: New Imaging Technology Penetration, US, 2009-2018
CHAPTER 3: REVASCULARIZATION DEVICES
- Exhibit 14: BAS Procedures, US, 2012-2018
- Exhibit 15: BAS Penetration, US, 2012-2018
- Exhibit 16: SCDES Procedures, US, 2010-2018
- Exhibit 17: SCDES Penetration, US, 2010-2018
- Exhibit 18: PCIs, by Type, as a % of Total, US, 2008-2018
- Exhibit 19: PCIs, by Type, US, 2008-2018
- Exhibit 20: PCI Growth, by Type, US, 2008-2018
- Exhibit 21: BAS in Development, 2007
- Exhibit 22: BAS Material Absorption Time
- Exhibit 23: Polymer-Free and Bioabsorbable Polymer-Coated Stents, 2007
- Exhibit 24: Synthetic Graft Procedures, 2011-2018
- Exhibit 25: Synthetic Graft Penetration, 2011-2018
- Exhibit 26: RNT Procedures, 2008-2018
- Exhibit 27: RNT Penetration, US, 2008-2018
CHAPTER 4: NEOVASCULARIZATION THERAPIES
- Exhibit 28: Therapeutic Angiogenesis Procedures, US, 2013-2018
- Exhibit 29: Therapeutic Angiogenesis Procedure Penetration, US, 2013-2018
APPENDIX A: MRG ACRONYMS AND INITIALISMS
APPENDIX B: ADDITIONAL COMPETITOR INFORMATION
|
Related Report
|
View Cart
